B2M and melanoma: Tail vein injections of WT and B2m-/- B16 melanoma cells did not alter the CD11b+ mature NK cell dominance, but it significantly decreased IVpos DP population and likely led to their conversion into CD11b+CD27- NK cells in the circulation (Figure S5B).